![](/img/cover-not-exists.png)
Phase I Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors
Erlichman, C., Hidalgo, M., Boni, J. P., Martins, P., Quinn, S. E., Zacharchuk, C., Amorusi, P., Adjei, A. A., Rowinsky, E. K.Volume:
24
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2005.01.8960
Date:
April, 2006
File:
PDF, 390 KB
english, 2006